Astrana Health Inc [ASTH] stock is trading at $29.38, up 7.98%. An important factor to consider is whether the stock is rising or falling in short-term value. The ASTH shares have gain 15.76% over the last week, with a monthly amount drifted -19.57%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Astrana Health Inc [NASDAQ: ASTH] stock has seen the most recent analyst activity on October 14, 2024, when TD Cowen initiated its Buy rating and assigned the stock a price target of $66. On July 11, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $50 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $54 on May 30, 2024. Jefferies initiated its recommendation with a Buy and recommended $50 as its price target on February 26, 2024. BofA Securities upgraded its rating to Buy for this stock on February 22, 2024, and upped its price target to $55. In a note dated January 24, 2024, Stifel initiated an Buy rating and provided a target price of $45 on this stock.
Astrana Health Inc [ASTH] stock has fluctuated between $23.12 and $63.20 over the past year. Currently, Wall Street analysts expect the stock to reach $70 within the next 12 months. Astrana Health Inc [NASDAQ: ASTH] shares were valued at $29.38 at the most recent close of the market. An investor can expect a potential return of 138.26% based on the average ASTH price forecast.
Analyzing the ASTH fundamentals
Astrana Health Inc [NASDAQ:ASTH] reported sales of 2.03B for the trailing twelve months, which represents a growth of 88.43%. Gross Profit Margin for this corporation currently stands at 0.43% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.06 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 27.64 points at the first support level, and at 25.90 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.42, and for the 2nd resistance point, it is at 31.47.
Ratios To Look Out For
For context, Astrana Health Inc’s Current Ratio is 1.67. On the other hand, the Quick Ratio is 1.90, and the Cash Ratio is 0.79. Considering the valuation of this stock, the price to sales ratio is 0.71, the price to book ratio is 1.98 and price to earnings (TTM) ratio is 32.85.
